91 related articles for article (PubMed ID: 37271662)
1. Bridging the specialty gap: Update on primary cutaneous lymphomas.
Olsen EA; Hodak E; Geskin L; Scarisbrick J;
J Am Acad Dermatol; 2024 Feb; 90(2):257-260. PubMed ID: 38043039
[No Abstract] [Full Text] [Related]
2. Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States.
Barta SK; Liu N; DerSarkissian M; Chang R; Ye M; Duh MS; Surinach A; Fanale M; Yu KS
Clin Lymphoma Myeloma Leuk; 2024 Feb; 24(2):e21-e32.e4. PubMed ID: 37919137
[TBL] [Abstract][Full Text] [Related]
3. Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients.
Gandham AR; Geller S; Dusza SW; Kupper TS; Myskowski PL
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e174-e180. PubMed ID: 38245472
[TBL] [Abstract][Full Text] [Related]
4. Causes of Death in Cutaneous T-Cell Lymphoma Patients.
Lebas E; Collins P; Somja J; Nikkels AF
Dermatology; 2023; 239(6):860-867. PubMed ID: 37611553
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.
Ion A; Popa IM; Papagheorghe LM; Lisievici C; Lupu M; Voiculescu V; Caruntu C; Boda D
Dis Markers; 2016; 2016():9602472. PubMed ID: 27821903
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma.
Glinos G; Wei G; Nosewicz J; Abdulla F; Chen PL; Chung C; Kaffenberger BH; Querfeld C; Shinohara MM; Sokol L; Zain J; Kumar A; Seminario-Vidal L
JAMA Dermatol; 2023 Feb; 159(2):192-197. PubMed ID: 36598766
[TBL] [Abstract][Full Text] [Related]
7. Descriptive Analysis and Factors Influencing Survival in Patients With Primary Cutaneous Gamma-Delta T Cell Lymphoma. A Retrospective National Cancer Database Study.
Ashok Kumar P; Sivapiragasam A; Wang D; Huang D; Gentile T
Clin Lymphoma Myeloma Leuk; 2023 Dec; 23(12):897-904. PubMed ID: 37690902
[TBL] [Abstract][Full Text] [Related]
8. Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage.
Navarro Matilla B; Ortiz Romero PL; Pujol Vallverdú RM; Combalia Escudero A; Zapata Paz I; González Barca E; Muniesa Montserrat C; Morillo Andújar M; Pérez Ferriols A; Román Curto C; Fernández de Misa Cabrera R; Hospital Gil M; Marín Niebla A; Rios Rull PJ; de la Cruz Vicente F; Izu Belloso RM; Martín García-Sancho A; Parera Amer ME; Córdoba Mascuñano R; Ramón Quiles MD; Saus Carreres A; Del Campo García R; Machan S; Viguera Ester P; Blanco Garnelo J
Actas Dermosifiliogr; 2024 Feb; 115(2):119-129. PubMed ID: 37689349
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients.
Ottevanger R; van Beugen S; Kersten JM; Evers AWM; Vermeer MH; Willemze R; Quint KD
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473299
[TBL] [Abstract][Full Text] [Related]
10. Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCL.
Hooper MJ; Veon FL; Enriquez GL; Nguyen M; Grimes CB; LeWitt TM; Pang Y; Case S; Choi J; Guitart J; Burns MB; Zhou XA
J Am Acad Dermatol; 2024 Feb; 90(2):e79. PubMed ID: 37797839
[No Abstract] [Full Text] [Related]
11. Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort study.
Trum NA; Chen L; Zain J; Rosen ST; Querfeld C
Br J Dermatol; 2024 Jan; ():. PubMed ID: 38282350
[No Abstract] [Full Text] [Related]
12. Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.
Preston JD; Jansen CS; Kosaraju S; Niyogusaba T; Zhuang TZ; Iwamoto SW; Hutto SK; Lechowicz MJ; Allen PB
CNS Oncol; 2023 Dec; 12(4):CNS105. PubMed ID: 37877303
[TBL] [Abstract][Full Text] [Related]
13. Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study.
Zhuang TZ; McCook-Veal A; Switchenko J; Niyogusaba T; Tarabadkar ES; Baird K; O'Leary C; Paulino D; Lechowicz MJ; Allen PB
Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):667-673. PubMed ID: 37271662
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series.
Tang H; Matsumoto N; Foss F; Xu M; Ahmed A
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e405-e410. PubMed ID: 37659965
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
